Back
TScan Therapeutics Stock Price Chart
Sponsored
TCRX
Sponsored
Elon Musk Dreams, Mode Mobile Delivers
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
19
TCRX
TScan Therapeutics
Last Price:
$3.06
Seasonality Move:
12.37%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TCRX is experiencing selling pressure, which indicates risk of future bearish movement.
TScan Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.04 | Buy |
20-day SMA: | 3.23 | Sell |
50-day SMA: | 4.2 | Sell |
200-day SMA: | 6.16 | Sell |
8-day EMA: | 3.06 | Buy |
20-day EMA: | 3.32 | Sell |
50-day EMA: | 4 | Sell |
200-day EMA: | 5.26 | Sell |
TScan Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.36 | Sell |
Relative Strength Index (14 RSI): | 37.2 | Sell |
Chaikin Money Flow: | -256186 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.78 - 4.26) | Sell |
Bollinger Bands (100): | (3.91 - 5.81) | Sell |
TScan Therapeutics Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for TScan Therapeutics Stock
Is TScan Therapeutics Stock a Buy?
-
TScan Therapeutics share price is 3.07 while TCRX 8-day simple moving average is 3.04, which is a Buy signal.
-
The stock price of TCRX is 3.07 while TScan Therapeutics 20-day SMA is 3.23, which makes it a Sell.
-
TScan Therapeutics 50-day simple moving average is 4.20 while TCRX share price is 3.07, making it a Sell technically.
-
TCRX stock price is 3.07 and TScan Therapeutics 200-day simple moving average is 6.16, creating a Sell signal.
TCRX Technical Analysis vs Fundamental Analysis
Sell
19
TScan Therapeutics (TCRX)
is a Sell
Is TScan Therapeutics a Buy or a Sell?
-
TScan Therapeutics stock is rated a SellThe current TScan Therapeutics [TCRX] share price is $3.07. The Score for TCRX is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
TScan Therapeutics Stock Info
Market Cap:
173.2M
Price in USD:
3.07
Share Volume:
315.3K
TScan Therapeutics 52-Week Range
52-Week High:
9.69
52-Week Low:
2.60
Sell
19
TScan Therapeutics (TCRX)
is a Sell
TScan Therapeutics Share Price Forecast
-
What is the TScan Therapeutics stock price today?The TScan Therapeutics stock price is 3.07 USD today.
-
Will TCRX stock go up or go down?TScan Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is TScan Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, TScan Therapeutics is overvalued.
Is TScan Therapeutics Stock a Buy?
-
TScan Therapeutics share price is 3.07 while TCRX 8-day exponential moving average is 3.06, which is a Buy signal.
-
The stock price of TCRX is 3.07 while TScan Therapeutics 20-day EMA is 3.32, which makes it a Sell.
-
TScan Therapeutics 50-day exponential moving average is 4.00 while TCRX share price is 3.07, making it a Sell technically.
-
TCRX stock price is 3.07 and TScan Therapeutics 200-day simple moving average is 5.26, creating a Sell signal.
Fundamental Analysis of TScan Therapeutics
Is TScan Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.08 per share.
Technical Analysis of TScan Therapeutics
Should I short TScan Therapeutics stock?
-
TCRX Moving Average Covergence Divergence (MACD) indicator is -0.36, suggesting TScan Therapeutics is a Sell
-
TScan Therapeutics Relative Strength Index (RSI) is 37.2, which suggest TScan Therapeutics is oversold
-
The Bollinger Bands (25) for TScan Therapeutics is (2.78 - 4.26), which suggest TScan Therapeutics is a Sell
-
The Bollinger Bands (100) for TScan Therapeutics is (3.91 - 5.81), which suggest TScan Therapeutics is a Sell
* TScan Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.